| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.39 | 0.01 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |